Calendar Cerevel Therapeutics Holdings, Inc.

Equities

CERE

US15678U1280

Market Closed - Nasdaq 04:00:04 2024-04-23 pm EDT 5-day change 1st Jan Change
42 USD -0.24% Intraday chart for Cerevel Therapeutics Holdings, Inc. +1.67% -0.94%

Chart calendar Cerevel Therapeutics Holdings, Inc.

93afad4826b80c.zbpOm4-xQ4rJbJCTNA3I4oFxG_bQWGyJ6DPCGHF6iqk._et-z835LvuKL8DeVTr-tuAzcqnoERzNjlCaWUcb8oT_2Tn6--tz24M4yQ~5a92dbc5313a978d4afbf76fc4e80986

Upcoming events on Cerevel Therapeutics Holdings, Inc.

2024-05-12 Q1 2024 Earnings Release (Projected)
2024-07-29 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)

Past events on Cerevel Therapeutics Holdings, Inc.

2024-02-16 09:00 am Extraordinary Shareholders Meeting
2023-11-30 09:10 am Evercore ISI HealthCONx Conference
2023-11-14 04:00 am Jefferies London Healthcare Conference
2023-11-01 08:00 am Q3 2023 Earnings Call
2023-11-01 06:30 am Q3 2023 Earnings Release
2023-09-12 09:30 am Morgan Stanley Global Healthcare Conference - Fireside Chat
2023-08-02 08:00 am Q2 2023 Earnings Call
2023-08-02 06:30 am Q2 2023 Earnings Release
2023-06-07 09:00 am Annual General Meeting
2023-05-10 01:00 pm Bank of America Healthcare Conference
2023-05-03 08:00 am Q1 2023 Earnings Call
2023-05-03 06:30 am Q1 2023 Earnings Release
2023-03-29 10:30 am Stifel CNS Day
2023-03-06 09:10 am Cowen Health Care Conference
2023-02-22 08:00 am FY 2022 Earnings Call
2023-02-22 06:30 am FY 2022 Earnings Release
2023-01-10 11:15 am JP Morgan Healthcare Conference
2022-11-29 03:30 pm Evercore ISI HealthCONx Conference
2022-11-16 03:00 pm Stifel Healthcare Conference
2022-11-14 Guggenheim Healthcare Talks Immunology & Neurology Day

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
-149
-146
-1.63%
-217
-207
-5.1%
-363
-349
-4.11%
-442
-417
-5.92%

-462

EBIT
Million USD
Released
Forecast
Spread
-149
-152
1.77%
-220
-211
-4.33%
-368
-358
-2.78%
-447
-421
-6.3%

-487

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-152
-166
8.17%
-225
-222
-1.41%
-351
-356
1.27%
-432
-404
-7.02%

-448

Net income
Million USD
Released
Forecast
Spread
-152
-166
8.18%
-225
-222
-1.38%
-352
-356
1.14%
-433
-405
-6.9%

-456

EPS
USD
Released
Forecast
Spread
-2,01
-3,97
49.37%
-1,65
-1,61
-2.37%
-2,32
-2,35
1.1%
-2,67
-2,50
-6.61%

-2,49

Announcement Date24/03/2101/03/2222/02/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBITDA
Million USD
Released
Forecast
Spread









-93,8
-93,3
-0.53%
-106
-94,4
-12.24%






-110
-104
-5.27%
-138
-108
-27.83%















EBIT
Million USD
Released
Forecast
Spread
-64,5
-55,5
-16.23%
-72,5
-62,5
-15.96%
-93,0
-70,9
-31.1%
-95,1
-93,3
-1.86%
-107
-100
-6.89%
-99,6
-109
8.39%
-96,8
-109
10.84%
-111
-103
-7.61%
-140
-113
-23.37%

-119


-120


-123


-127


-125

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-59,1
-57,3
-3.04%
-68,3
-64,3
-6.16%
-90,5
-74,1
-22.15%
-99,9
-94,7
-5.55%
-92,6
-98,1
5.54%
-104
-110
5.61%
-99,4
-111
10.17%
-96,2
-103
6.56%
-132
-104
-27.18%

-110


-109


-113


-115


-123

Net income
Million USD
Released
Forecast
Spread
-59,1
-57,3
-3.04%
-68,3
-65,1
-4.89%
-90,5
-74,4
-21.58%
-99,9
-96,0
-4.1%
-92,8
-97,5
4.83%
-104
-106
1.61%
-99,5
-109
8.9%
-96,4
-102
5.78%
-133
-105
-26.66%

-110


-109


-113


-115


-123

EPS
USD
Released
Forecast
Spread
-0,40
-0,39
-1.42%
-0,46
-0,42
-9.63%
-0,61
-0,48
-27.88%
-0,66
-0,62
-6.48%
-0,59
-0,62
5.45%
-0,67
-0,67
0.72%
-0,63
-0,69
8.32%
-0,61
-0,65
5.83%
-0,76
-0,60
-26.62%

-0,61


-0,60


-0,63


-0,62


-0,72

Announcement Date01/03/2210/05/2201/08/2208/11/2222/02/2303/05/2302/08/2301/11/2327/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CERE Stock
  4. Calendar Cerevel Therapeutics Holdings, Inc.